Drawing for CARDIOVANT

USPTO serial 50163481

CARDIOVANT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CARDIOVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joyce M. Ferraro

Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of cardiovascular diseases, disorders and conditions; biological preparations for medical or therapeutic purposes for the treatment of cardiovascular diseases, disorders and conditionsACTIVE—
042Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biologic therapeutic research services; scientific research in the fields of pharmaceutical and biological therapeutic preparations, clinical trials and examinations carried out after the introduction of medicines on the market; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicines, clinical trials and post-market trialsACTIVE—
044Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biological preparations for the prevention and treatment of diseases, disorders and conditionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance